期刊文献+

肝细胞肝癌门静脉癌栓相关蛋白表达研究 被引量:8

Proteomic analysis on portal vein tumor thrombus-associated proteins for hepatocellular carcinoma
原文传递
导出
摘要 目的应用比较蛋白组学研究与肝细胞肝癌门静脉癌栓形成相关的蛋白质分子标记物。方法利用双向凝胶电泳(2-DE)对同一患者的肝癌原发灶组织和其门静脉癌栓组织进行总蛋白的分离,两组之间的差异蛋白通过质谱分析和蛋白数据库搜索鉴定,并用免疫印迹(Western 印迹)法对差异蛋白点进行进一步检测验证。结果共鉴定出20有意义的蛋白质。12个蛋白仅在肝癌原发灶组织表达或表达明显增高,其中包括半乳糖苷凝-1(Galectin-1)、高迁移率族蛋白-1(HMGBI)、过氧化氧化还原蛋白1(peroxiredoxin 1)、亲环蛋白 B(Cyclophilin B)、增殖细胞核抗原(PCNA)等,同时我们发现8个蛋白仅门静脉癌栓中表达或者高表达包括膜联蛋白5(Annexin V)、TriosephosphateIsomerase。对于门静脉癌栓组织高表达的 Annexin V,应用 Western 印迹在蛋白水平上验证了2-DE 结果。结论肝癌门静脉癌栓形成与多种蛋白质相关,其中 Annexin V 高表达可能发挥重要作用。 Objective A comparative proteomic approach was used to analyze proteins relevant to portal vein tumor thrombus forming. Methods proteins extracted from five pairs of matched primary tumor/ tumor thrombus samples in the same patient were separated by two-dimensional gel electrophoresis (2-DE). Selected proteins exhibiting statistically significant alternations were identified by mass spectrometry. Western blotting was further performed to examine the expression of the candidate proteins. Result There were 20 significant proteins were identified in total, Among the 20 spots, 12 proteins were up-regulated proteins in primary tumor tissue, including Galectin-1, HMGBI, peroxiredoxin l, Cyclophilin B, PCNA. whereas 8 were up-regulated proteins in tumor thrombus samples, including Annexin V, Triosephosphate Isomerase. Western blotting Confirmed the difference of Annexin V on protein level. Conclusion There are many proteins associated with the formation of PVTT in HCC. The overexpression of Annexin V may serve as a biomarker for early detection and therapeutic targets to HCC with PVTT.
出处 《中华医学杂志》 CAS CSCD 北大核心 2007年第30期2094-2097,共4页 National Medical Journal of China
基金 上海市启明星后培养计划基金(2004QMH1408) 上海市教委曙光学者培养计划基金(2005)
关键词 肝细胞癌 门静脉癌栓 双向电泳 蛋白组学 Hepatocellular carcinoma Portal vein tumor thrombus Two-dimensional electrophoresis Proteome
  • 相关文献

参考文献11

  • 1Esnaola NF, Mirza N, Lauwers GY, et al. Comparison of clinicopathologic characteristics and outcomes after resection in patients with hepatocellular carcinoma treated in the United States, France and Japan, 2003 ,238:711-719.
  • 2Ohkubo T, Yamamoto J, Sugawara Y, et al. Surgical results for hepatocellular carcinoma with macroscopic portal vein tumor thrombosis. Am Coll Surg ,2000,191:657-660.
  • 3Tsai TJ, Chau GY, Lui WY, et al. Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. 2000.127:603-608.
  • 4程树群,吴孟超,陈汉,沈锋,杨家和,丛文铭,王培军,赵玉祥.癌栓分型对肝细胞性肝癌合并门静脉癌栓治疗及预后的指导意义[J].中华医学杂志,2004,84(1):3-5. 被引量:67
  • 5Tang ZY, Ye SL, Lin YK, et al. A decade's studies on metastasis of hepatocellular carcinoma. J Cancer Res Clin Oncol,2004,130: 187-196.
  • 6Le Naour F. Contribution of proteomics to tumor immunology. Proteomics, 2001, 1:1295-302.
  • 7Van den Brule FA, Buicu C. Galectin-1 modulates human melanoma cell adhesion to laminin. Biochem Biophys Res Commun, 1995, 209 : 760-767.
  • 8Sparatore B, Patrone M, Passalacqua M, et al. Activation of A431 human carcinoma cell motility by extracellular high-mobility group box 1 protein and epidermal growth factor stimuli,2005,389:215-221.
  • 9Chuma M, Saeki N, Yamamoto Y, et al. Expression profiling in hepatocellular carcinoma with intrahepatic metastasis : identification of high-mobility group 1 ( Y ) protein as a molecular marker of hepatocellular carcinoma metastasis. Keio J Med,2004, 53:90-97.
  • 10Hawkins TE, Merrifield CJ, Moss SE. Calcium signaling and annexins. Cell Biochem Biophys,2000,33:275-296.

二级参考文献16

  • 1Parkin DM, Pisani P, Ferlay J, et al. Global cancer statistics. CA Cancer J Clin, 1999, 49: 33-64.
  • 2Toyosaka A, Okamoto E, Mitsunobu M, et al. Intrahepatic metastases in hepatocellular carcinoma: evidence for spread via the portal vein as an efferent vessel. Am J Gastroenterol, 1996, 91:1610-1615.
  • 3Cedrone A, Rapaccini GL, Pompili M et al. Portal vein thrombosis complicating hepatocellular carcinoma. Value of ultrasound-guided fine-needle biopsy of the thrombus in the therapeutic management. Liver, 1996,16: 94-98.
  • 4Sumiyoshi Y, Yamashita Y, Maekawa T, et al. Expression of CD44, vascular endothelial growth factor, and proliferating cell nuclear antigen in severe venous invasional colorectal cancer and its relationship to liver metastasis. Surg Today, 2000,30: 323-327.
  • 5Taraboletti G, Sonzogni L, Vergani V, et al. Posttranscriptional stimulation of endothelial cell matrix metalloproteinases 2 and 1 by endothelioma cells. Exp Cell Res, 2000, 258:384-394.
  • 6Ye QH, Qin LX, Forgues M, et al. Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med, 2003,9: 416-423.
  • 7Fields S. Proteomics. Proteomics in genomeland. Science, 2001, 291:1221-1224.
  • 8Issaq HJ, Conrads TP, Prieto DA,et al. SELDI-TOF MS for diagnostic proteomics. Anal Chem, 2003,75:148-155.
  • 9Lehrer S, Roboz J, Ding H, et al. Putative protein markers in the sera of men with prostatic neoplasms. BJU In, 2003, 92: 223-225.
  • 10Sauter ER, Zhu W, Fan XJ, et al. Proteomic analysis of nipple aspirate fluid to detect biologic markers of breast cancer. Br J Cancer, 2002, 86: 1440-1443.

共引文献89

同被引文献59

引证文献8

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部